EGFR and colorectal cancer: Resistance to MEK inhibition in gastric and colorectal cancer cells with mutated KRAS occurs as a result of downregulation of Gene 33 by MEK inhibition, which increases EGFR signaling to AKT by reducing the inhibition of EGFR by Gene 33 [163].